Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Jenkins

Showing results (51-60 of 269) with videos related to

Pageof 27
Sort By:
Human Pathology|April 24, 2009
CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinomaWilliam R Sukov, Rhett P Ketterling, Donna J Lager, et al.
Journal of Neuropathology and Experimental Neurology|March 9, 2026
Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomasBlake A Ebner, Cristiane M Ida, Thomas M Kollmeyer, et al.
Cancer Research|November 17, 2006
Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletionCarlise R Bethel, Dennis Faith, Xiang Li, et al.
Journal of Neuropathology and Experimental Neurology|May 3, 2024
Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 casesM Adelita Vizcaino, Caterina Giannini, Daniel Lalich, et al.
Human Pathology|April 17, 2012
A cytogenetic analysis of 2 cases of phosphaturic mesenchymal tumor of mixed connective tissue typeRondell P Graham, Jennelle C Hodge, Andrew L Folpe, et al.
Plos One|April 4, 2015
Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysisJennifer Mason Lobo, Adam P Dicker, Christine Buerki, et al.
Cancer Genetics and Cytogenetics|September 15, 2007
Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormalityCristiane M Ida, Kristen A Rolig, Rachael L Hulshizer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2002
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progressionJunqi Qian, Kiyoshi Hirasawa, David G Bostwick, et al.
Plos One|January 5, 2012
A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brainGobinda Sarkar, Geoffry L Curran, Eric Mahlum, et al.
Archives of Pathology & Laboratory Medicine|October 28, 2020
HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ HybridizationKatherine B Geiersbach, Daniel R Sill, Reid G Meyer, et al.
Pageof 27

Showing results (51-60 of 269) with videos related to

Sort By:
Pageof 27
Human Pathology|April 24, 2009
CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinomaWilliam R Sukov, Rhett P Ketterling, Donna J Lager, et al.
Journal of Neuropathology and Experimental Neurology|March 9, 2026
Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomasBlake A Ebner, Cristiane M Ida, Thomas M Kollmeyer, et al.
Cancer Research|November 17, 2006
Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletionCarlise R Bethel, Dennis Faith, Xiang Li, et al.
Journal of Neuropathology and Experimental Neurology|May 3, 2024
Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 casesM Adelita Vizcaino, Caterina Giannini, Daniel Lalich, et al.
Human Pathology|April 17, 2012
A cytogenetic analysis of 2 cases of phosphaturic mesenchymal tumor of mixed connective tissue typeRondell P Graham, Jennelle C Hodge, Andrew L Folpe, et al.
Plos One|April 4, 2015
Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysisJennifer Mason Lobo, Adam P Dicker, Christine Buerki, et al.
Cancer Genetics and Cytogenetics|September 15, 2007
Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormalityCristiane M Ida, Kristen A Rolig, Rachael L Hulshizer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 18, 2002
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progressionJunqi Qian, Kiyoshi Hirasawa, David G Bostwick, et al.
Plos One|January 5, 2012
A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brainGobinda Sarkar, Geoffry L Curran, Eric Mahlum, et al.
Archives of Pathology & Laboratory Medicine|October 28, 2020
HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ HybridizationKatherine B Geiersbach, Daniel R Sill, Reid G Meyer, et al.
Pageof 27